Literature DB >> 11992280

The changing age and seasonal profile of pertussis in Canada.

Danuta M Skowronski1, Gaston De Serres, Diane MacDonald, Wrency Wu, Carol Shaw, Jane Macnabb, Sylvie Champagne, David M Patrick, Scott A Halperin.   

Abstract

During the postvaccine era in Canada, most cases of pertussis have been reported in children <5 years of age, with the highest incidence, morbidity, and mortality in infants <1 year old. Population-based data, with very high laboratory confirmation rates and hospital separation and mortality statistics, chronicle the changing age and seasonal profile associated with pertussis over recent successive outbreaks in British Columbia, Canada. A large outbreak during 2000 highlights 2 important changes to the postvaccine profile. For the first time in Canada, the incidence of pertussis among preteens and teens surpassed that of all other age groups. At the same time, a decreasing incidence of pertussis among infants and preschool children highlights reduced susceptibility in the very young. Recent changes in the childhood immunization program (including introduction of an acellular pertussis vaccine), waning immunity, and changes in laboratory methods are considered in explaining these 2 simultaneous but divergent trends in the pertussis profile.

Entities:  

Mesh:

Year:  2002        PMID: 11992280     DOI: 10.1086/340280

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  60 in total

1.  Whooping cough--a continuing problem.

Authors:  N S Crowcroft; Joseph Britto
Journal:  BMJ       Date:  2002-06-29

2.  Pertussis control in Canada.

Authors:  Scott A Halperin
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

3.  Modelling the long-term dynamics of pre-vaccination pertussis.

Authors:  Ganna Rozhnova; Ana Nunes
Journal:  J R Soc Interface       Date:  2012-06-20       Impact factor: 4.118

4.  Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries.

Authors:  H Broutin; C Viboud; B T Grenfell; M A Miller; P Rohani
Journal:  Proc Biol Sci       Date:  2010-06-09       Impact factor: 5.349

Review 5.  What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors:  Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

6.  Imperfect vaccine-induced immunity and whooping cough transmission to infants.

Authors:  Jennie Lavine; Hélène Broutin; Eric T Harvill; Ottar N Bjørnstad
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

7.  A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.

Authors:  P M Luz; C T Codeço; G L Werneck; C J Struchiner
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

8.  Pertussis in rural populations of Saskatchewan (1995 to 2003): incidence, seasonality, and differences among cases.

Authors:  David Vickers; Raúl C Mainar-Jaime; Punam Pahwa
Journal:  Can J Public Health       Date:  2006 Nov-Dec

9.  Has the change to acellular pertussis vaccine improved or worsened pertussis control?

Authors:  Scott A Halperin; Gaston De Serres
Journal:  CMAJ       Date:  2006-11-07       Impact factor: 8.262

10.  Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination.

Authors:  J C Blackwood; D A T Cummings; S Iamsirithaworn; P Rohani
Journal:  Epidemics       Date:  2016-03-19       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.